News
5h
Zacks.com on MSNIs Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...
Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...
The GOP tax bill repeals the Inflation Reduction Act’s price controls for drugs for rare diseases.
While their functions are diverse, myosins are similar in structure. NMII is so much like cardiac myosin, which keeps the ...
Drug enforcement agencies across the nation play a crucial role in fighting the drug epidemic.The High Intensity Drug ...
Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced ...
Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.
While ALTO-203 missed its depression-related endpoints, improvements in EEG biomarkers, attention and wakefulness point to ...
"Imcranib 100", the first targeted cancer drug in tablet form developed and produced in Thailand, is the result of the ...
When surgeons dissect tissue to remove a tumor or make a repair, they must work cautiously, relying on electrophysical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results